Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition
Yoko Katsuno(University of California, San Francisco), Rik Derynck(Biologie du Développement et Cellules Souches)
Cited by 228
Related Papers
TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
|The EMBO Journal|2007|569
Smad2 Is Essential for Maintenance of the Human and Mouse Primed Pluripotent Stem Cell State
|Journal of Biological Chemistry|2013|88